Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when LifeStance Health Group, Inc. publishes a filing, an earnings call transcript or a press release.

Get LFST alerts

About David Bourdon

David Bourdon is recorded as CEO and Board Member at LifeStance Health Group, Inc. (LFST) and CFO at Centene Corp (CNC). The newest filing on record that lists David Bourdon as CEO and Board Member at LifeStance Health Group, Inc. (LFST) is dated April 22, 2026. LifeStance Health Group, Inc. reported in an 8-K filed February 27, 2025 that David Bourdon was appointed Class II director, effective March 3, 2025. LifeStance Health Group, Inc. reported in an 8-K filed February 27, 2025 that David Bourdon was appointed Chief Executive Officer, effective March 3, 2025. LifeStance Health Group, Inc. reported in an 8-K filed November 3, 2022 that David Bourdon was appointed Chief Financial Officer and Treasurer, effective November 10, 2022. The proxy statement of LifeStance Health Group, Inc. reports total compensation of $6,645,380 for David Bourdon in fiscal 2025, including a base salary of $657,692. Disclosed compensation is on record for 4 fiscal years. David Bourdon has spoken on 6 earnings calls and 1 other investor event across 1 company, most recently for LifeStance Health Group, Inc. on September 15, 2026. LifeStance Health Group, Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Centene Corp is classified in the Healthcare Plans industry within the Healthcare sector. Other leadership on record at LifeStance Health Group, Inc. includes Kenneth Burdick (CEO and Chairman), Ryan McGroarty (CFO), Lisa Miller (COO) and 7 others.

“The Board of Directors also appointed Mr. Bourdon to serve as a Class II director of the Company, effective as of the CEO Start Date.”
LifeStance Health Group, Inc. Form 8-K, filed February 27, 2025 · Read the filing
“On February 25, 2025, the Board of Directors of LifeStance Health Group, Inc. ("LifeStance" or the "Company") promoted David Bourdon to serve as the Company's Chief Executive Officer effective as of March 3, 2025 (the "CEO Start Date").”
LifeStance Health Group, Inc. Form 8-K, filed February 27, 2025 · Read the filing

David Bourdon on recent calls

“First of all, thanks for having us, Craig. It's always great to be here with you. Outpatient mental health industry is unlike anything else in the healthcare ecosystem as you know it today.”
CEO, 24th Annual Morgan Stanley Healthcare Conference ·
“This was another exceptional quarter for Lifestance. We exceeded each of our guided metrics for the quarter, delivering remarkable revenue growth of over 26% and adjusted EBITDA margins that exceeded 15%.”
CEO, LifeStance Health Second Quarter 2026 Earnings Call ·
“We had an exceptional start to the year at Lifestance. We exceeded each of our guided metrics with strong revenue growth of over 21% and more than $50 million in adjusted EBITDA, a 48% increase over last year.”
CEO, LifeStance Health Group, Inc. Q1 FY2026 Earnings Call ·
“I'm incredibly proud of the LifeStance team for the exceptional results we delivered in the third quarter. For the past 3 years, we have met or exceeded our guided metrics, a testament to our consistency, execution and the resilience of our commercial pay hybrid model.”
CEO, LifeStance Health Group, Inc. Q3 FY2025 Earnings Call ·
“I'm pleased to report a solid quarter to start the year. We exceeded each of our guided metrics and remain confident in delivering on the full year guidance ranges that we previously provided.”
CEO, LifeStance Health Group, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at LifeStance Health Group, Inc.

Leadership on record at Centene Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 LifeStance Health Group, Inc. (LFST) $657,692 $6,645,380
2024 LifeStance Health Group, Inc. (LFST) $500,000 $3,446,530
2023 LifeStance Health Group, Inc. (LFST) $500,000 $2,354,954
2022 LifeStance Health Group, Inc. (LFST) $51,923 $4,992,543

Recent activity